Compile Data Set for Download or QSAR
Report error Found 456 Enz. Inhib. hit(s) with all data for entry = 13338
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782091BDBM782091(US12447153, Example 148)
Affinity DataIC50: 0.600nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782242BDBM782242(US12447153, Example 299)
Affinity DataIC50: 1.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782306BDBM782306(US12447153, Example 363)
Affinity DataIC50: 1.80nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782342BDBM782342(US12447153, Example 399)
Affinity DataIC50: 1.90nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782029BDBM782029(US12447153, Example 86)
Affinity DataIC50: 2.30nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782046BDBM782046(US12447153, Example 103)
Affinity DataIC50: 2.90nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782028BDBM782028(US12447153, Example 85)
Affinity DataIC50: 3.10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782040BDBM782040(US12447153, Example 97)
Affinity DataIC50: 3.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782096BDBM782096(US12447153, Example 153)
Affinity DataIC50: 4nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782398BDBM782398(US12447153, Example 455)
Affinity DataIC50: 4.10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782264BDBM782264(US12447153, Example 321)
Affinity DataIC50: 4.60nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782388BDBM782388(US12447153, Example 445)
Affinity DataIC50: 4.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782274BDBM782274(US12447153, Example 331)
Affinity DataIC50: 4.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782115BDBM782115(US12447153, Example 172)
Affinity DataIC50: 5.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 781982BDBM781982(US12447153, Example 39)
Affinity DataIC50: 5.5nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782088BDBM782088(US12447153, Example 145)
Affinity DataIC50: 5.90nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 781973BDBM781973(US12447153, Example 30)
Affinity DataIC50: 6nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782126BDBM782126(US12447153, Example 183)
Affinity DataIC50: 6.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 781978BDBM781978(US12447153, Example 35)
Affinity DataIC50: 6.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782009BDBM782009(US12447153, Example 66)
Affinity DataIC50: 6.80nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782281BDBM782281(US12447153, Example 338)
Affinity DataIC50: 7nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782347BDBM782347(US12447153, Example 404)
Affinity DataIC50: 7.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782156BDBM782156(US12447153, Example 213)
Affinity DataIC50: 7.30nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782309BDBM782309(US12447153, Example 366)
Affinity DataIC50: 7.30nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782030BDBM782030(US12447153, Example 87)
Affinity DataIC50: 7.5nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782287BDBM782287(US12447153, Example 344)
Affinity DataIC50: 7.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782121BDBM782121(US12447153, Example 178)
Affinity DataIC50: 8nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782265BDBM782265(US12447153, Example 322)
Affinity DataIC50: 8.10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782262BDBM782262(US12447153, Example 319)
Affinity DataIC50: 8.10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782245BDBM782245(US12447153, Example 302)
Affinity DataIC50: 8.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 781956BDBM781956(US12447153, Example 13)
Affinity DataIC50: 8.40nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 781981BDBM781981(US12447153, Example 38)
Affinity DataIC50: 8.5nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782349BDBM782349(US12447153, Example 406)
Affinity DataIC50: 8.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782015BDBM782015(US12447153, Example 72)
Affinity DataIC50: 8.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782303BDBM782303(US12447153, Example 360)
Affinity DataIC50: 8.80nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782020BDBM782020(US12447153, Example 77)
Affinity DataIC50: 9nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782344BDBM782344(US12447153, Example 401)
Affinity DataIC50: 9.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782017BDBM782017(US12447153, Example 74)
Affinity DataIC50: 9.20nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782065BDBM782065(US12447153, Example 122)
Affinity DataIC50: 9.30nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782288BDBM782288(US12447153, Example 345)
Affinity DataIC50: 9.40nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782120BDBM782120(US12447153, Example 177)
Affinity DataIC50: 9.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782340BDBM782340(US12447153, Example 397)
Affinity DataIC50: 9.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782305BDBM782305(US12447153, Example 362)
Affinity DataIC50: 9.70nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782358BDBM782358(US12447153, Example 415)
Affinity DataIC50: 9.80nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782034BDBM782034(US12447153, Example 91)
Affinity DataIC50: 9.80nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782335BDBM782335(US12447153, Example 392)
Affinity DataIC50: 9.80nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782174BDBM782174(US12447153, Example 231)
Affinity DataIC50: 10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782301BDBM782301(US12447153, Example 358)
Affinity DataIC50: 10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782013BDBM782013(US12447153, Example 70)
Affinity DataIC50: 10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 782219BDBM782219(US12447153, Example 276)
Affinity DataIC50: 10nMAssay Description:Compound potencies were determined using CisBio's HTRF Kinease-TK assay technology. The kinases were incubated with 250 nM TK-substrate biotin (C...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/9/2026
Entry Details
US Patent

Displayed 1 to 50 (of 456 total ) | Next | Last >>
Jump to: